PPAR? agonist. It decreasing insulin levels, VEGF production, and blood pressure and induces cell cycle arrest in stomach cancer cells. (C003B-254946)

Ciglitazone is a thiazolidinedione that exhibits antihypertensive, anticancer, and anti-diabetic activities. Ciglitazone acts as an agonist at PPAR? receptors, decreasing insulin levels, VEGF production, and blood pressure. In cellular models of stomach cancer, ciglitazone induces G1 phase cell cycle arrest, inhibits ERK phosphorylation, and suppresses cell growth.

UPC:

51183701

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

C3210-1 mg

CAS:

74772-77-3